Showing results (11-20 of 57) with videos related to
Sort By:
Pageof 6
Cancer Control : Journal of the Moffitt Cancer Center|November 1, 2005
Cutaneous melanoma: prognostic factorsJade Homsi, Mohammed Kashani-Sabet, Jane L Messina, et al.Palliative Medicine|December 18, 2009
Symptom severity and distress in advanced cancerJordanka Kirkova, Declan Walsh, Lisa Rybicki, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 25, 2002
The impact of a palliative medicine consultation service in medical oncologyJade Homsi, Declan Walsh, Kristine A Nelson, et al.The American Journal of Hospice & Palliative Care|August 13, 2002
A phase II study of hydrocodone for cough in advanced cancerJade Homsi, Declan Walsh, Kristine A Nelson, et al.The American Journal of Hospice & Palliative Care|September 25, 2009
A comparative study of 2 sustained-release morphine preparations for pain in advanced cancerJade Homsi, Declan Walsh, Wael Lasheen, et al.Clinical Genitourinary Cancer|June 25, 2026
Long-Term Survival Outcomes of Immune Checkpoint Inhibitor-based Combination Therapies in Favorable-Risk Metastatic Renal Cell Carcinoma: An Updated Pairwise and Network Meta-AnalysisSusu Zhou, Sanjay Rao Gergal Gopalkrishna Rao, Vishw Patel, et al.Melanoma Research|June 13, 2009
Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patientsJade Homsi, Agop Y Bedikian, Kevin B Kim, et al.Melanoma Research|October 1, 2010
Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanomaJade Homsi, Agop Y Bedikian, Nicholas E Papadopoulos, et al.American Journal of Clinical Oncology|June 10, 2009
Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanomaNicholas E Papadopoulos, Agop Bedikian, Sigrid Ring, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 26, 2012
Comparison of two dosing schedules of palonosetron for the prevention of nausea and vomiting due to interleukin-2-based biochemotherapyRahat Noor, Agop Y Bedikian, Sandy Mahoney, et al.Pageof 6